{"id":13977,"date":"2026-06-16T21:11:11","date_gmt":"2026-06-16T21:11:11","guid":{"rendered":"https:\/\/medical-article.com\/?p=13977"},"modified":"2026-06-16T21:11:11","modified_gmt":"2026-06-16T21:11:11","slug":"new-cancer-biotech-unveils-27m-for-dual-targeting-prostate-cancer-drug","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=13977","title":{"rendered":"New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/06\/prostate-cancer-multivalent-biotherapies-startup-peptide-conjugate-psma-folate-receptor-alpha\/\"><\/a><\/p>\n<p>MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/06\/prostate-cancer-multivalent-biotherapies-startup-peptide-conjugate-psma-folate-receptor-alpha\/\">New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News.<\/p>\n","protected":false},"author":0,"featured_media":13978,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-13977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13977"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13977"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13977\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/13978"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}